7Th International Congress on Amino Acids and Proteins Vienna, Austria

Total Page:16

File Type:pdf, Size:1020Kb

7Th International Congress on Amino Acids and Proteins Vienna, Austria Amino Acids (2001) 21: 1–90 7th International Congress on Amino Acids and Proteins Vienna, Austria August 6–10, 2001 Abstracts Co-Presidents: Steve Schaffer, Mobilel, AL, U.S.A. Michael Fountoulakis, Basel, Switzerland Gert Lubec, Vienna, Austria Contents Analysis................................................................................ 3 Biology ................................................................................ 10 Proteomics . 14 Medicine . 22 Metabolism/Nutrition . 25 Neurobiology . 35 Neuroscience . 45 Plant Amino Acids . 56 Physiology/Exercise and Sport . 59 Polyamines . 63 Synthesis . 68 Taurine ................................................................................ 74 Amino Acids Transport . 79 Addendum . 86 3 Analysis Fully automated HPLC based analysis of cysteine and related used for calculation of the degree of substitution in case of compounds in plasma using on line microdialysis as sample peptide-conjugates. The results of amino acid analysis were preparation verified by the data of ES mass spectrometry method. [This study was supported by grants from Hungarian E. Bald Research Fund (OTKA) T 030838, T025834, T032425, F034886 Department of Environmental Chemistry, University of ´Lodz´, and from the Ministry of Education (FKFP/0153/2001).] Poland Low molecular weight thiols play important roles in metabolism and homeostasis. While plasma thiols, including Free and bound cysteine in homocystinuria: assessment of metabolically related cysteine, glutathione, and homocysteine, cysteine and glutathione status are being investigated as potential indicators of health status A. Briddon1, I. P. Hargreaves1, and P. J. Lee2 and disease risk, trace levels, poor stability, and the lack of 1 structural properties necessary for the production of signals Department of Clinical Biochemistry, and compatible with common detection methods have hampered 2 Metabolic Unit, The National Hospital for Neurology and their accurate assessment. The facile oxidation of sulfhydryl Neurosurgery, London, U.K. compounds results in a variety of disulfide forms in vivo. To The raised concentration of protein bound homocysteine in determine total plasma thiols – the sum of protein-bound forms, homocystinuric (HCU) patients displaces protein bound oxidized low-molecular-mass forms, and free reduced thiols – it cysteine and increases the free/bound cysteine ratio in plasma. is necessary to reduce disulfide bonds. In this presentation, a This ratio is independent of albumin concentration. Results new procedure for fully automated assay of total cysteine, from 31HCU patients were compared to 40 controls. Free cys- cysteinylglycine, glutathione, and homocysteine in human tine concentrations in HCU were poorly discriminated from the plasma is outlined. The oxidized and protein-bound thiols frac- control range but the total cysteine results were almost invari- tions are converted into their reduced forms employing sodium ably lower than control data. This appears to result from an borohydride, and following derivatization with 2-chloro-1- increased free/bound cysteine ratio in HCU [mean (range) for methylquinolinium tetrafluoroborate and deproteinization by control 0.50 (0.22–0.71) and for HCU 0.76 (0.32–1.75); P 5 on line microdialysis, the S-quinolinium derivatives of analytes 0.0005]. Ex vivo protein binding experiments in albumin solu- are separated, from each other and internal standard, and quan- tion revealed the free/bound cysteine ratio to be linearly related tified by ion-pair reversed-phase HPLC with ultraviolet detec- to the amount of homocysteine bound (r 5 0.907, P , 0.001). tion. The whole unattended instrument acquisition time is We conclude that measurement of total cysteine is essential for 13min with no manual processing of sample. As a result about assessment of the true cysteine status in HCU. However, any 80 samples a day can be assayed for total cysteine and related cysteine deficit, or alteration to free/bound cysteine ratios, does compounds. The method is linear within the normal and patho- not obviously effect glutathione synthesis as assessed by mea- logical ranges of thiols in humans and its sensitivity, precision surement of plasma total glutathione. and accuracy fulfils experimental and clinical requirements. Free D-amino acids in vertebrates Determination of S-carboxymethyl-cysteine in cyclo-peptides 1 1 2 and peptide-conjugates containing thioether bond H. Brückner , R. Paetzold , and A. Schieber 1 Interdisciplinary Research Center, Institute of Nutritional 1 1 1 S. Bo´´sze , G. Mezo´´ , H. Medzihradszky-Schweiger , Science, Department of Food Sciences, University of Z. Skribanek2, and F. Hudecz1 Giessen, and 1 Research Group of Peptide Chemistry, Hungarian Academy 2 Institute of Food Technology, Section Plant Foodstuff of Sciences, Eötvös L. University, Budapest, and Technology, University of Hohenheim, Stuttgart, Germany 2 Gedeon Richter Ltd., Budapest, Hungary In continuation of work on the screening of mammals for Chemically stable thioether bond is frequently applied for the occurrence of free D-amino acids (D-AAs), here we present the preparation of cyclopeptides and of peptide-conjugates pos- data on quantities determined in urine and blood plasma of sessing free SH group in one of the partner molecules. For the guinea pig, rabbit, goat, dromedary and cat, in the blood serum introduction of such bond the free thiol group of cysteine reacts of fish, and in the brains of mole rat, rabbit, pig, bovine, seal, with haloacetyl group attached to amino function of N-terminal and rob. AAs were isolated by cation exchanger, converted amino acid or lysine side chain of the peptide. The homogeneity into their N(O)-pentafluoro amino acid 2-propyl esters and and the amino acid composition of new compounds was quantified on a Chirasil-L-Val capillary column using mass checked by amino acid analysis, analytical RP-HPLC and mass spectrometric detection as described. spectrometry. Qualitative and quantitative determination of Representative data of animals investigated (n 5 2–3) are S-carboxymethyl-cysteine (SMC) derived from this thioether shown in the Table. As can be seen free D-AAs were detected linkage containing moiety was developed. Prior to amino acid in the orders Rodentia (Cavia aperea f. porcellus, guinea pig); analysis samples were hydrolysed in 6N HCl in sealed and Lagomorpha (Oryctolagus cuniculus f. domestica, rabbit); evacuated tubes at 110°C for 24, 36 or 48hrs depending on the Artiodactyla (Capra aegagrus f. hircus, goat); Artiodactyla structure of molecules. The amino acid composition of the com- (Camelus dromedaries, dromedary); Carnivora (Felis libyca f. pounds was determined by two independent methods: using catus, cat); and Osteichthyes (Gadus morrhua, codfish). Largest pre-column derivatization with o-phtaldialdehyde (OPA) rea- amounts of D-AAs were excreted with the urine. Free D-Ser gent and post-column derivatization with ninhydrin. The ap- (% relative to L-Ser) was detected in the brains (n 5 1–2; pearance of SCM verified the success of cyclization and can be cerebrum, wet weight) of mole (Talpa europaea, Insectivora) 4 Table 1. Quantities of D-amino acids (D-AA) in body fluids of vertebrates [% D 5 100 D/(D 1 L)] guinea rabbit goat piga) urine urine serum urine plasma D-AA µmol/L %D µmol/L %D µmol/L %D µmol/L %D µmol/L %D Ala 452.9 61.9 50.2 53.5 3.4 1.3 3.7 5.2 0.5 1.0 Val 30.7 10.9 1.2 4.4 – – – – – – Thr 96.1 15.3 – – – – – 0.4 – – Pro 3.2 1.4 2.3 2.9 0.5 0.2 – 2.9 ,0.1 0.1 Ser 99.5 27.2 245.4 69.8 2.5 0.9 2.5 12.6 0.2 0.9 Asx 17.9 11.8 31.5 30.2 1.1 1.1 4.0 16.5 0.1 2.3 Met 49.3 68.4 – – – – – – – – Phe – – 4.3 15.2 – – – – – – Glx 71.7 8.5 18.0 13.1 0.8 0.2 11.7 8.8 0.2 0.1 Tyr – – 16.9 26.8 – – – – – – Orn 89.7 33.7 9.0 19.5 0.6 0.7 0.2 3.0 – – Lys 0.9 9.7 7.3 2.5 0.8 0.7 0.2 0.6 0.7 1.7 dromedary cata) codfish urine serum urine serum serumb) D-AA µmol/L %D µmol/L %D µmol/L %D µmol/L %D nmol/L %D Ala 2.5 11.3 4.2 0.6 57.9 32.0 4.0 0.5 46 0.5 Val – – – – 7.4 9.9 – – – – Thr – – – – 4.2 1.4 – – – – Pro 0.5 1.9 – – 0.9 4.4 1.5 0.8 12 0.4 Ser 2.9 7.9 – – 159.9 61.6 2.0 0.8 – – Asx 3.9 14.8 1.8 1.2 18.4 50.9 1.0 2.0 27 4.3 Met – – – – 164.8 49.4 – – – – Phe– ––––––––– Glx 14.7 18.8 1.5 0.2 28.3 5.3 2.6 0.2 43 0.9 Tyr– ––––1.5–––– Orn 1.9 5.8 – – 12.6 32.5 – – 8 1.7 Lys 0.5 1.2 1.4 0.7 61.4 23.0 1.2 0.4 41 0.7 (2) refers to not detected or not determinable; Asx 5 Asp 1 Asn; Glx 5 Glu 1 Gln; His, Arg, Trp, Cys not determined; a) feed fortified with DL-Met; b) nmol/g lyophilized serum. (339nmol/g; 21.6%); Sprague-Dawley rat (Rattus norvegicus, Rodentia) (n 5 6; 98–381nmol/g; 9.8–13.7%); rabbit (152nmol/ The hydrolysis method was extensively studied, in several g; 11.3%); pig (Sus scrofa f. domestica, Artiodactyla) (221nmol/ time/temperature combinations, in order to avoid racemization. g; 13.4%); bovine (Bos primigenius f. taurus, Artiodactyla) The classical HCl 6M with and without phenol was tested as (284nmol/g; 23.6%); seal (Phoca vitulina, Carnivora) well as methylsulfonic acid 4M, described as producing less (136nmol/g; 3.8%), and rob (Halichoerus grypus, Carnivora) racemization. Indeed, the last acid induced less formation of the (218nmol/g; 5.4%). From the date it is concluded that D-AAs D-aminoacids.
Recommended publications
  • Synthesis of Conformationally Constrained Glutamate Analogues and Their Preliminary Evaluation As Glutamate Transport Inhibitors
    University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 2002 Synthesis of conformationally constrained glutamate analogues and their preliminary evaluation as glutamate transport inhibitors Travis Taylor Denton The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Denton, Travis Taylor, "Synthesis of conformationally constrained glutamate analogues and their preliminary evaluation as glutamate transport inhibitors" (2002). Graduate Student Theses, Dissertations, & Professional Papers. 9450. https://scholarworks.umt.edu/etd/9450 This Dissertation is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion.
    [Show full text]
  • Issn: 2455-7080
    ISSN: 2455-7080 Contents lists available at http://www.albertscience.com ASIO Journal of Experimental Pharmacology & Clinical Research (ASIO-JEPCR) Volume 1, Issue 1, 2016, 01-07 AN OVERVIEW OF TUBERCULOSIS MANAGEMENT: MECHANISM AND THERAPEUTIC APPLICATIONS Nidhi Singh Joint Replacement Surgery Research Unit, Fortis Escort Hospital, Jaipur, Rajasthan, India ARTICLE INFO ABSTRACT Tuberculosis infections have exceptional virulence factors compared to other Review Article History pathogens and they infect host cell and persist inside phagosomes. First Received: 29 October, 2015 symptoms of active pulmonary TB can include weight loss, night sweats, fever, Accepted: 05 January, 2016 and loss of appetite etc. The infection can either go into remission or become more serious with onset of chest pain and coughing up bloody sputum. The exact Corresponding Author: symptoms of extra-pulmonary TB vary according to the site of infection in the body. The Mantoux tuberculin skin test, also called as the PPD (purified protein Nidhi Singh derivative) test, is primarily used to identify TB infection. According to their clinical utility the anti-TB drugs can be divided into, two categories; one is first Joint Replacement Surgery line, these drugs have high anti-tubercular efficiency as well as low toxicity; are Research Unit, Fortis Escort used routinely, as for examples- Rifampin (R), Isoniazid (H), Streptomycin (S), Hospital, Jaipur, Rajasthan, India Pyrazinamide (Z), Ethambutol (E) and another is second line, these drugs have either low anti-tubercular efficacy or high toxicity or both; are used in special circumstances only. There are six classes of second-line drugs likes amino Email: [email protected] glycosides, fluoro quinolones, polypeptides, thioamides, cycloserine, p-amino salicylic acid.
    [Show full text]
  • United States Patent (10) Patent No.: US 8,969,514 B2 Shailubhai (45) Date of Patent: Mar
    USOO896.9514B2 (12) United States Patent (10) Patent No.: US 8,969,514 B2 Shailubhai (45) Date of Patent: Mar. 3, 2015 (54) AGONISTS OF GUANYLATECYCLASE 5,879.656 A 3, 1999 Waldman USEFUL FOR THE TREATMENT OF 36; A 6. 3: Watts tal HYPERCHOLESTEROLEMIA, 6,060,037- W - A 5, 2000 Waldmlegand et al. ATHEROSCLEROSIS, CORONARY HEART 6,235,782 B1 5/2001 NEW et al. DISEASE, GALLSTONE, OBESITY AND 7,041,786 B2 * 5/2006 Shailubhai et al. ........... 530.317 OTHER CARDOVASCULAR DISEASES 2002fOO78683 A1 6/2002 Katayama et al. 2002/O12817.6 A1 9/2002 Forssmann et al. (75) Inventor: Kunwar Shailubhai, Audubon, PA (US) 2003,2002/0143015 OO73628 A1 10/20024, 2003 ShaubhaiFryburg et al. 2005, OO16244 A1 1/2005 H 11 (73) Assignee: Synergy Pharmaceuticals, Inc., New 2005, OO32684 A1 2/2005 Syer York, NY (US) 2005/0267.197 A1 12/2005 Berlin 2006, OO86653 A1 4, 2006 St. Germain (*) Notice: Subject to any disclaimer, the term of this 299;s: A. 299; NS et al. patent is extended or adjusted under 35 2008/0137318 A1 6/2008 Rangarajetal.O U.S.C. 154(b) by 742 days. 2008. O151257 A1 6/2008 Yasuda et al. 2012/O196797 A1 8, 2012 Currie et al. (21) Appl. No.: 12/630,654 FOREIGN PATENT DOCUMENTS (22) Filed: Dec. 3, 2009 DE 19744O27 4f1999 (65) Prior Publication Data WO WO-8805306 T 1988 WO WO99,26567 A1 6, 1999 US 2010/O152118A1 Jun. 17, 2010 WO WO-0 125266 A1 4, 2001 WO WO-02062369 A2 8, 2002 Related U.S.
    [Show full text]
  • Chloroquine Stimulates Cl Secretion by Ca Activated Cl Channels in Rat
    Chloroquine Stimulates Cl2 Secretion by Ca2+ Activated Cl2 Channels in Rat Ileum Ning Yang1., Zhen Lei2., Xiaoyu Li1, Junhan Zhao1, Tianjian Liu1, Nannan Ning1, Ailin Xiao1, Linlin Xu1, Jingxin Li1* 1 Department of Physiology, Shandong University School of Medicine, Jinan, China, 2 Department of Anesthesiology, Qilu Hospital, Shandong University, Jinan, China Abstract Chloroquine (CQ), a bitter tasting drug widely used in treatment of malaria, is associated gastrointestinal side effects including nausea or diarrhea. In the present study, we investigated the effect of CQ on electrolyte transport in rat ileum using the Ussing chamber technique. The results showed that CQ evoked an increase in short circuit current (ISC) in rat ileum at lower concentration (#561024 M ) but induced a decrease at higher concentrations ($1023 M). These responses were not affected by tetrodotoxin (TTX). Other bitter compounds, such as denatoniumbenzoate and quinine, exhibited similar 24 + effects. CQ-evoked increase in ISC was partly reduced by amiloride(10 M), a blocker of epithelial Na channels. Furosemide 24 + + 2 2 (10 M), an inhibitor of Na -K -2Cl co-transporter, also inhibited the increased ISC response to CQ, whereas another Cl channel inhibitor, CFTR(inh)-172(1025M), had no effect. Intriguingly, CQ-evoked increases were almost completely abolished by niflumic acid (1024M), a relatively specific Ca2+-activated Cl2 channel (CaCC) inhibitor. Furthermore, other CaCC inhibitors, such as DIDS and NPPB, also exhibited similar effects. CQ-induced increases in ISC were also abolished by thapsigargin(1026M), a Ca2+ pump inhibitor and in the absence of either Cl2 or Ca2+ from bathing solutions. Further studies demonstrated that T2R and CaCC-TMEM16A were colocalized in small intestinal epithelial cells and the T2R agonist CQ evoked an increase of intracelluar Ca2+ in small intestinal epithelial cells.
    [Show full text]
  • Poster Abstracts
    POSTER ABSTRACTS Society of Toxicology (MASOT) www.masot.org Fall 2015 Scientific Meeting October 13th, 2015 Abstract 01 Tracking Inflammatory Macrophage Accumulation in the Lung during Ozone- induced Lung Injury in Mice M Francis, M Mandal, C. Sun, H Choi, JD Laskin, DL Laskin Rutgers University, Piscataway, NJ Ozone induced lung injury is associated with an accumulation of pro- and antiinflammatory macrophages (MP) in the lung which have been implicated in tissue injury and repair. In these studies, we used in vivo tracking techniques to investigate the origin of cell. Initially we generated bone marrow (BM) chimeric mice by adoptive transfer of BM cells from GFP+ mice into irradiated C57BL/6 mice. After 4 weeks, mice were exposed to air or ozone (0.8 ppm, 3 h). Macrophages were isolated from lungs 24- 72 h later, stained with fluorescent labeled antibodies, and analyzed by flow cytometry. Approximately 98% of BM cells were found to be GFP+ while only 5% were GFP+ in control lungs. Ozone exposure resulted in a marked increase in infiltrating mature GFP+CD11b+F4/80+ MP into the lung. Two populations, Ly6CHi proinflammatory and Ly6CLo antiinflammatory were identified. Proinflammatory GFP+Ly6CHi MP increased rapidly after ozone and remained elevated, increases in antiinflammatory GFP+Ly6CLo were transient. To assess potential mechanisms mediating the accumulation of these MP subpopulations in the lung, we used mice lacking Ccr2, a chemokine receptor involved in proinflammatory MP trafficking. Loss of Ccr2 resulted in decreased numbers of infiltrating CD11b+ MP in the lung. This was due to a selective reduction in proinflammatory Ly6CHi MP.
    [Show full text]
  • Inhibition of Monoamine Oxidase in 5
    Br. J. Pharmac. (1985), 85, 683-690 Inhibition ofmonoamine oxidase in 5- hydroxytryptaminergic neurones by substitutedp- aminophenylalkylamines Anna-Lena Ask, Ingrid Fagervall, L. Florvall, S.B. Ross1 & Susanne Ytterborn Research Laboratories, Astra Likemedel AB, S-151 85 Si3dertilje, Sweden 1 A series ofsubstituted p-aminophenethylamines and some related compounds were examined with regards to the inhibition ofmonoamine oxidase (MAO) in vivo inside and outside 5-hydroxytryptamin- ergic neurones in the rat hypothalamus. This was recorded as the protection against the irreversible inhibition of MAO produced by phenelzine by determining the remaining deaminating activity in the absence and presence ofcitalopram using a low (0.1 yIM) concentration of ['4CJ-5-hydroxytryptamine (5-HT) as substrate. 2 Some ofthe phenethylamines were much more potent inside than outside the 5-hydroxytryptamin- ergic neurones. This neuronal selectivity was antagonized by pretreatment of the rats with norzimeldine, a 5-HT uptake inhibitor, which indicates that these compounds are accumulated in the 5-HT nerve terminals by the 5-HT pump. 3 Selectivity was obtained for compounds with dimethyl, monomethyl or unsubstituted p-amino groups. An isopropyl group appears to substitute for the dimethylamino group but with considerably lower potency. Compounds with 2-substitution showed selectivity for aminergic neurones and this effect decreased with increased size of the substituent. The 2,6-dichloro derivative FLA 365 had, however, no neuronal selective action but was a potent MAO inhibitor. Substitutions in the 3- and 5- positions decreased both potency and selectivity. 4 Prolongation ofthe side chain with one methylene group abolished the preference for the MAO in 5-hydroxytryptaminergic neurones although the MAO inhibitory potency remained.
    [Show full text]
  • Monoamine Oxidase Inhibitory Properties of Some Methoxylated and Alkylthio Amphetamine Derivatives Strucrure-Acfivity RELA TIONSHIPS Ma
    Biochemieal PhannaeoloR)'. Vol. 54. pp. 1361-1369, 1997. ISSN 0006-2952/97/$17.00 + 0.00 © 1997 Elsevier Scienee Ine. Al! rights reserved. PIl SOOO6-2952(97)00405·X ELSEVIER Monoamine Oxidase Inhibitory Properties of Some Methoxylated and Alkylthio Amphetamine Derivatives STRUcruRE-ACfIVITY RELA TIONSHIPS Ma. Cecilia Scorza,* Cecilia Carrau,* Rodolfo Silveira,* GemId Zapata,Torres,t Bruce K. Casselst and Miguel Reyes,Parada*t *DIVISIÓNBIOLOGíACELULAR,INSTITUTODEINVESTIGACIONESBIOLÓGICASCLEMENTeEsTABlE, CP 11600, MONTEVIOEO,URUGUAY;ANDtDEPARTAMENTODEQUíMICA, FACULTADDECIENCIAS,UNIVERSIDADDECHILE, SANTIAGO,CHILE ABSTRACT. The monoamine oxidase (MAO) inhibitory propenies of a series of amphetamine derivatives with difTerent substituents at or around rhe para position of the aromaric ring were evaluateJ. i¡, in viero stuJies in which a crude rar brain mirochllndrial suspension was used as rhe source of MAO, several compounds showed a srrong (ICS0 in rhe submicromolar range), selecrive, reversible, time-independenr, and concenrrarion-related inhibition of MAO-A. After i.p. injection, the compounds induced an inerease of serotonin and a decrease of j-hydroxyindoleacetic acid in the raphe nuclei and hippocampus, confinning rhe in virro results. The analysis of structure-activity relationships indicates rhat: molecules with amphetamine-Iike structure and different substitutions nn the aromaric ring are potentially MAO-A inhibitors; substituents at different positions of the aromatic ring moditY the porency but have litde inf1uence "n the selectiviry; substituents at rhe para position sllch as ,lmino, alkoxyl. halogens. or alkylthio produce a significant increase in rhe acrivity; the para-substituent musr be an e1ectron Jonor; hulky ~roups next to rhe para subsriruent Icad ro a Jecrease in the actÍ\'ityi ,ubstiruents loearcd ar posirions more Jistant ,m rhe aromaric ring havc less intluence anJ, even when the subsriruent is '1 halogen (CI, Br), an increase in rhe acrivity "f rhe cllmpound is llbtained.
    [Show full text]
  • The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
    Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota.
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • Microglial Glutathione and Glutamate: Regulation Mechanisms
    Microglial glutathione and glutamate: Regulation mechanisms Victoria Anne Honey Fry UCL Institute of Neurology A thesis submitted for the degree of Doctor of Philosophy (Ph.D.) 1 I, Victoria Fry, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Microglia, the immune cells of the central nervous system (CNS), are important in the protection of the CNS, but may be implicated in the pathogenesis of neuroinflammatory disease. Upon activation, microglia produce reactive oxygen and nitrogen species; intracellular antioxidants are therefore likely to be important in their self-defence. Here, it was confirmed that cultured microglia contain high levels of glutathione, the predominant intracellular antioxidant in mammalian cells. The activation of microglia with lipopolysaccharide (LPS) or LPS + interferon- was shown to affect their glutathione levels. GSH levels in primary microglia and those of the BV-2 cell line increased upon activation, whilst levels in N9 microglial cells decreased. - Microglial glutathione synthesis is dependent upon cystine uptake via the xc transporter, which exchanges cystine and glutamate. Glutamate is an excitatory neurotransmitter whose extracellular concentration is tightly regulated by excitatory amino acid transporters, as high levels cause toxicity to neurones and other CNS cell types through overstimulation of - glutamate receptors or by causing reversal of xc transporters. Following exposure to LPS, increased extracellular glutamate and increased levels of messenger ribonucleic acid - (mRNA) for xCT, the specific subunit of xc , were observed in BV-2 and primary microglial cells, suggesting upregulated GSH synthesis.
    [Show full text]
  • Brain CYP2D6 and Its Role in Neuroprotection Against Parkinson's
    Brain CYP2D6 and its role in neuroprotection against Parkinson’s disease by Amandeep Mann A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Graduate Department of Pharmacology and Toxicology University of Toronto © Copyright by Amandeep Mann 2011 Brain CYP2D6 and its role in neuroprotection against Parkinson’s disease Amandeep Mann Doctor of Philosophy, 2011 Graduate Department of Pharmacology and Toxicology University of Toronto Abstract The enzyme CYP2D6 can metabolize many centrally acting drugs and endogenous neural compounds (e.g. catecholamines); it can also inactivate neurotoxins such as 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP), 1,2,3,4-tetrahydroisoquinoline (TIQ) and β- carbolines that have been associated with Parkinson’s disease (PD). CYP2D6 is ideally situated in the brain to inactivate these neurotoxins. The CYP2D6 gene is also highly polymorphic, which leads to large variation in substrate metabolism. Furthermore, CYP2D6 genetically poor metabolizers are known to be at higher risk for developing PD, a risk that increases with exposure to pesticides. Conversely, smokers have a reduced risk for PD and smokers are suggested to have higher brain CYP2D6 levels. Our studies furthered the characterization and involvement of CYP2D6 in neuroprotection against PD. METHODS: We investigated the effects of CYP2D6 inhibition on MPP+-induced cell death in SH-SHY5Y human neuroblastoma cells. We compared levels of brain CYP2D6, measured by western blotting, between human smokers and non-smokers, between African Green monkeys treated with saline or nicotine, and between PD cases and controls. In addition, we assessed changes in human brain CYP2D6 expression with age.
    [Show full text]
  • VDAC1 Is Essential for Neurite Maintenance and the Inhibition Of
    www.nature.com/scientificreports OPEN VDAC1 is essential for neurite maintenance and the inhibition of its oligomerization protects Received: 4 July 2019 Accepted: 4 September 2019 spinal cord from demyelination Published: xx xx xxxx and facilitates locomotor function recovery after spinal cord injury Vera Paschon1, Beatriz Cintra Morena1, Felipe Fernandes Correia1, Giovanna Rossi Beltrame1, Gustavo Bispo dos Santos2, Alexandre Fogaça Cristante2 & Alexandre Hiroaki Kihara 1 During the progression of the neurodegenerative process, mitochondria participates in several intercellular signaling pathways. Voltage-dependent anion-selective channel 1 (VDAC1) is a mitochondrial porin involved in the cellular metabolism and apoptosis intrinsic pathway in many neuropathological processes. In spinal cord injury (SCI), after the primary cell death, a secondary response that comprises the release of pro-infammatory molecules triggers apoptosis, infammation, and demyelination, often leading to the loss of motor functions. Here, we investigated the functional role of VDAC1 in the neurodegeneration triggered by SCI. We frst determined that in vitro targeted ablation of VDAC1 by specifc morpholino antisense nucleotides (MOs) clearly promotes neurite retraction, whereas a pharmacological blocker of VDAC1 oligomerization (4, 4′-diisothiocyanatostilbene-2, 2′-disulfonic acid, DIDS), does not cause this efect. We next determined that, after SCI, VDAC1 undergoes conformational changes, including oligomerization and N-terminal exposition, which are important steps in the triggering of apoptotic signaling. Considering this, we investigated the efects of DIDS in vivo application after SCI. Interestingly, blockade of VDAC1 oligomerization decreases the number of apoptotic cells without interfering in the neuroinfammatory response. DIDS attenuates the massive oligodendrocyte cell death, subserving undisputable motor function recovery. Taken together, our results suggest that the prevention of VDAC1 oligomerization might be benefcial for the clinical treatment of SCI.
    [Show full text]